Jump to main content
Jump to site search


Gold(I)–BODIPY–imidazole bimetallic complexes as new potential anti-inflammatory and anticancer trackable agents

Author affiliations

Abstract

Two new gold(I)–BODIPY–imidazole based trackable therapeutic bimetallic complexes have been synthesized and fully characterized. They display strong antiproliferative properties on several types of cancers including colon, breast, and prostate and one of them presents a significant anti-inflammatory effect. Additionally, the two compounds could be visualised in vitro by confocal microscopy in the submicromolar range.

Graphical abstract: Gold(i)–BODIPY–imidazole bimetallic complexes as new potential anti-inflammatory and anticancer trackable agents

Back to tab navigation

Supplementary files

Publication details

The article was received on 15 Apr 2017, accepted on 21 May 2017 and first published on 22 May 2017


Article type: Paper
DOI: 10.1039/C7DT01377A
Citation: Dalton Trans., 2017, Advance Article
  •   Request permissions

    Gold(I)–BODIPY–imidazole bimetallic complexes as new potential anti-inflammatory and anticancer trackable agents

    A. Trommenschlager, F. Chotard, B. Bertrand, S. Amor, L. Dondaine, M. Picquet, P. Richard, A. Bettaïeb, P. Le Gendre, C. Paul, C. Goze and E. Bodio, Dalton Trans., 2017, Advance Article , DOI: 10.1039/C7DT01377A

Search articles by author

Spotlight

Advertisements